Asia · Regional markets · CNBC-TV18

Dr Reddy's Laboratories gets USFDA tentative nod for twice-yearly HIV prevention injection

Published by CNBC-TV18 · India 4 h ago

Dr Reddy’s has received USFDA tentative approval for its twice-yearly injectable lenacapavir for HIV prevention, with plans to make it available across 120 countries outside the…

Read the full article on CNBC-TV18 Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Mint

Dr Reddy's Laboratories gets USFDA tentative nod for twice-yearly HIV prevention injection

Share

Also worth reading

Nasdaq 100 Enters Correction as Megacap Results Amplify AI Fears

S&P 500 ends down; Apple dips ahead of quarterly report

IPO fundraising rises 30% to record ₹84,400 crore in H1FY27: Report

Goldman restricts traders and bankers from using some AI tools — Bloomberg

Apple results beat Wall Street expectations on strong iPhone sales

EU businesses seek greater cooperation, not the restrictive policies from Brussels: China Daily editorial